DHDavid B. Haslam

David B. Haslam

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


David B. Haslam has a total of 325 co-authors. Here are the top co-authors by number of shared publications:

  • Aleksey Porollo

    Department of Biostatistics, Health Informatics and Data Sciences, University of Cincinnati College of Medicine , Cincinnati, OH 45267

    3 shared publications
  • Kelly E. Lake

    Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

    3 shared publications
  • Lucille Langenberg

    Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

    3 shared publications
  • Mary Allen Staat

    Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA

    3 shared publications
  • Nathan Luebbering

    Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

    3 shared publications
  • Pooja Khandelwal

    Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

    3 shared publications

Latest Publications

  • Open Access

    Staphylococcus aureus mupirocin susceptibility testing in a neonatal intensive care unit reveals horizontal transmission of a highly resistant strain

    by Andrea L. Ankrum, David B. Haslam, Joel E. Mortensen, Felicia Scaggs-Huang

    Objectives: Determine the prevalence of Staphylococcus aureus mupirocin resistance in a Neonatal Intensive Care Unit (NICU) population to inform decolonization regimen decisions. Investigate highly resistant methicillin-resistant S. aureus (MRSA) isolates for stain relatedness and horizontal transmission events. Methods: Mupirocin susceptibility of S. aureus isolates from nares of NICU patients was evaluated by E-test. Strain relatedness of nine MRSA isolates with high-level mupirocin resistance along with one blood isolate was analyzed by whole-genome sequencing. An epidemiological investigation was performed using electronic medical record data. Results: Overall S. aureus mupirocin resistance was 12.7% (89/102) with MRSA isolates exhibiting a 38% (11/29) resistance rate. All sequenced MRSA isolates were the same strain and possessed the mupA gene. Five patients tested positive on admission, four patients acquired the strain in our NICU, and one patient’s acquisition status was indeterminant. Conclusions: Overall, mupirocin resistance among S. aureus isolates was low; however, MRSA isolates demonstrated a higher-than-expected resistance rate. A highly resistant strain was introduced into our NICU and transmitted to several patients, most likely due to a gap in contact precaution implementation. Simplified mupirocin susceptibility testing, clearer interpretation standards and validated alternative therapies for all age groups should be prioritized if mupirocin continues to be nationally recommended and implemented as a decolonization therapy.

  • Human milk oligosaccharide (2′-FL) modifies the gut microbiome in children after bone marrow transplant

    by Kristie N. Ramos, Lucille Langenberg, Kelly E. Lake, Colin Hoerth, Nathan Luebbering, David B. Haslam, David Newburg, Ardythe L. Morrow, Nicholas J. Ollberding, Ashley Teusink-Cross, et al.

    Dysbiosis after allogeneic hematopoietic stem cell transplant (allo-HSCT) predisposes to acute gastrointestinal (GI) graft-versus-host disease (GVHD). Human milk oligosaccharides (HMOs) are prebiotics that establish a favorable intestinal microbiome. We hypothesized that peritransplant HMOs would reduce dysbiosis, and conducted a prospective phase 1/2 study in which 70 patients received oral, daily 2’-fucosyllactose (2’-FL), the most abundant HMO, from start of conditioning through day +30. Primary phase 1 and phase 2 end points were safety and tolerability of 2′-FL and longitudinal preservation of microbiome diversity, respectively. Phase 1 and phase 2 patients with ≥60% adherence were evaluated by correlative analyses. Twenty-nine age-matched patients with available samples in our institutional biorepository served as contemporary controls. 2′-FL was safe and well tolerated on the phase 1 study, which established dosing for the phase 2 study. Shannon diversity was preserved in 2′-FL recipients and declined from baseline to day +30 in controls (P = .04). Generalized linear mixed model analysis revealed higher association of Bifidobacteria and Blautia with 2′-FL (adjusted P< .05). Higher fecal isoleucine (P = .005), tyrosine (P = .05), and taurine (P = .04) were observed in 2′-FL recipients, all associated with protection and regeneration of intestinal epithelium. Lower plasma regulatory islet-derived 3α (P = .053) and suppressor of tumorigenicity 2 levels (P = .038) were observed in 2′-FL recipients compared with controls. Incidence of grade II-IV acute GI GVHD was 0% in 2′-FL recipients compared with 17% in controls (P = .009). Adenovirus reactivation was 0% in 2′-FL recipients compared with 17% in controls (P = .009). 2′-FL is safe and modifies the gut microbiome in children after allo-HSCT. This trial was registered at www.clinicaltrials.gov as #NCT04263597.


  • Longitudinal Skin Bacterial Cluster Associated With Protection Against Allergic Co‐Morbidity in Pediatric Atopic Dermatitis

    by Arya Dahal, Wan Chi Chang, Brittany Grashel, David Morgan, Dan Spagna, Do Hyup Kim, Seiya Sachdeva, Kieran J. Phelan, Latha Satish, Jocelyn M. Biagini, et al.

    Background: Atopic dermatitis (AD) is an inflammatory skin condition that often portends the development of allergic comorbidities. Despite evidence supporting the role of the skin microbiome in AD, its temporal patterns and associations with risk or protection for allergic co‐morbidity remain unclear. Our objective is to characterize core species of the pediatric AD bacterial microbiome, assess microbial networks and clusters, and identify global microbial changes relevant to AD and the atopic march. Methods: We performed metagenomic shotgun sequencing on 353 non‐lesional skin samples from children in the Mechanisms of Progression of Atopic Dermatitis to Asthma in Children (MPAACH) cohort across 5 annual visits. We assessed taxonomic composition and analyzed longitudinal skin microbial patterns with progression to allergic co‐morbidities. Results: We identified 436 distinct species. Shannon diversity and richness declined with age, and socioeconomic factors explained the variance in species composition. Staphylococcus aureus (SA) was more abundant in severe AD. Cluster 5, comprised of typically gut‐associated microbes, was more abundant in non‐sensitized children who did not develop allergic co‐morbidities over time. Conclusions: Our analyses revealed key patterns in core taxa, diversity and abundance of the skin microbiome over time in early life and highlighted previously unexplored factors such as socioeconomic status as key contributors to the variability in species composition. Abundance of SA confers risk, while gut‐associated microbes may offer protection, influencing the clinical trajectory of AD and the atopic march. Thus, these results provide a novel and comprehensive understanding of the temporal dynamics of the skin microbiota in pediatric AD.

  • Clinical Care Practices and Microbiome-Associated Bloodstream Infection Risk Across Geographically Distinct Neonatal Intensive Care Units

    by Yanping Xu, Henry Akinbi, Zheng Shen, Jiajun Zhu, Liping Shi, Lizhong Du, David B Haslam

    Background: Bloodstream infections (BSIs) remain a major cause of disease and death in preterm infants. Although BSI pathogens vary geographically, the role of local microbial colonization patterns and clinical practices in driving these differences is not well understood. Methods: We conducted a prospective cohort study on 127 preterm infants from 2 geographically distinct neonatal intensive care units: the University of Cincinnati Medical Center (UCMC) in Cincinnati, Ohio, and Children's Hospital, Zhejiang University School of Medicine (ZCH) in Hangzhou, China. Metagenomic sequencing was performed in 669 longitudinal stool and skin samples collected during the first 3 weeks of life. Associations between microbiome composition, clinical factors, and BSI epidemiology were evaluated using generalized linear mixed and random forest models. Results: Distinct gut and skin microbiome profiles were observed in the comparison between neonatal intensive care units, and these corresponded closely with local BSI patterns. Staphylococcus aureus predominated at UCMC, while Klebsiella pneumoniae and Enterococcus species were more common at ZCH. Skin microbiota showed strong association with BSI isolates, implicating the skin as an underrecognized potential reservoir for pathogen translocation. Linear mixed models and random forest analysis revealed that clinical practices, including intravenous catheter placement and antibiotic exposure, had greater influence on microbiome composition than geographic location alone. Conclusions: Our findings demonstrate that modifiable clinical care practices shape the developing microbiome of preterm infants and contribute to geographic differences in BSI epidemiology. The skin microbiome represents a potentially significant risk factor for invasive infection. Further work to clarify how specific clinical practices influence pathogen colonization may inform strategies to reduce the incidence of BSIs in preterm infants.

  • Open Access

    SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals

    by Bernadeta Dadonaite, Allison R. Burrell, Jenni Logue, Helen Y. Chu, Daniel C. Payne, David B. Haslam, Mary A. Staat, Jesse D. Bloom

    The immune response to viral infection is shaped by past exposures to related virus strains, a phenomenon known as imprinting. For SARS-CoV-2, much of the population has been imprinted by a viral spike from an early strain, either through vaccination or infection during the early stages of the COVID-19 pandemic. As a consequence of this imprinting, infection with more recent SARS-CoV-2 strains primarily boosts cross-reactive antibodies elicited by the imprinting strain. Here we compare the neutralizing antibody specificities of imprinted individuals versus infants infected with a recent strain. Specifically, we use pseudovirus-based deep mutational scanning to measure how spike mutations affect neutralization by the serum antibodies of adults and children imprinted by the original vaccine versus infants with a primary infection by a XBB* variant. While the serum neutralizing activity of the imprinted individuals primarily targets the spike receptor-binding domain (RBD), serum neutralizing activity of infants only infected with XBB* mostly targets the spike N-terminal domain (NTD). In these infants, secondary exposure to the XBB* spike via vaccination shifts more of the neutralizing activity towards the RBD, although the specific RBD sites targeted are different than for imprinted adults. The dramatic differences in neutralization specificities among individuals with different exposure histories likely impact SARS-CoV-2 evolution.


  • Open Access

    Complement-producing maternal microchimeric cells override infection susceptibility in complement-deficient murine offspring

    by Giang Pham, Raymond E. Diep, Lucien H. Turner, David B. Haslam, Sing Sing Way

    To the Editor: Long-term persistence of vertically transferred maternal cells occurs ubiquitously in mammalian offspring. The presence of these exceptionally rare maternal microchimeric cells (MMcs), with ensuing immunological tolerance to noninherited maternal antigen (NIMA), is associated with a variety of remarkable phenotypes including serological resistance to noninherited maternal HLA sensitization (1), improved long-term survival of NIMA-matched renal allografts (2), neonatal heart block (3), type 1 diabetes (4), and cross-generational reproductive fitness with expanded accumulation of NIMA-specific Tregs (5). Here, we considered whether MMcs may confer other physiological benefits beyond these immunological features linked with antigenicity. A provocative consideration is whether phenotypically WT MMcs can reduce disease severity in autosomal recessive disorders caused by defective or missing proteins. Given a shared susceptibility to infection caused by complement deficiency in humans and mice and enriched MMcs in the liver, where C3 and other complement components are produced, this hypothesis was investigated by evaluating complement levels and infection susceptibility of C3 NIMA mice (C3-/-mice born to C3 +/-mothers) compared with genetically identical C3-/-mice born to complement-deficient mothers, along with C3 +/-littermate controls (Figure 1A and Supplemental Figure 1; supplemental material available online with this article; https://doi.org/10.1172/JCI187001DS1). We found increased serum C3 levels in C3 NIMA mice compared with C3-/-mice born to complement-deficient mothers, albeit at levels still considerably reduced compared with levels in C3 +/-controls (Figure 1B). C3-/-mice are highly susceptible to E. coli, and an intermediate dosage (15,000 CFU) that accentuates this susceptibility was used for intravenous infection to further investigate the functional consequences of complement-producing MMcs (Supplemental Figure 2). These experiments showed that the normally high bacterial burden in tissues of infected C3-/-mice were reduced in C3 NIMA mice (Figure 1C), demonstrating that being born to complement-sufficient mothers can dominantly affect infection susceptibility of otherwise genetically identical complement-deficient mice. To verify importance of C3 +/-MMcs, we evaluated C3 levels and infection susceptibility after MMc depletion using antibodyor pregnancy-induced MMc displacement in male and female C3 NIMA mice, respectively. For antibody MMc depletion, transgenic mice with constitutive cell-surface expression of OVA (5, 6) were intercrossed with C3-/-mice to generate C3 OVA NIMA offspring born to C3 +/-OVA +/-mothers (Supplemental Figure 3). Transforming OVA with C3 into NIMAs in this fashion allowed MMc depletion using anti-OVA IgG, and verification of loss of MMc by quantifying OVA + genomic DNA in tissues such as heart, liver, and uterus, which consistently contain the highest MMc levels (5, 6). These experiments showed that C3 +/-OVA +/-MMc depletion


  • A randomized phase 2 trial of oral vitamin A for graft-versus-host disease in children and young adults

    by Pooja Khandelwal, Lucille Langenberg, Nathan Luebbering, Kelly E. Lake, Abigail Butcher, Kylie Bota, Kristie N. Ramos, Cynthia Taggart, Hannah K Choe, Sumithira Vasu, et al.

    Vitamin A plays a key role in the maintenance of gastrointestinal homeostasis and promotes a tolerogenic phenotype in tissue resident macrophages. We conducted a prospective randomized double-blinded placebo-controlled clinical trial in which 80 recipients of hematopoietic stem cell transplantation (HSCT) were randomized 1:1 to receive pretransplant high-dose vitamin A or placebo. A single oral dose of vitamin A of 4000 IU/kg, maximum 250 000 IU was given before conditioning. The primary end point was incidence of acute graft-versus-host disease (GVHD) at day +100. In an intent-to-treat analysis, incidence of acute GVHD was 12.5% in the vitamin A arm and 20% in the placebo arm (P = .5). Incidence of acute gastrointestinal (GI) GVHD was 2.5% in the vitamin A arm (P = .09) and 12.5% in the placebo arm at day +180. Incidence of chronic GVHD was 5% in the vitamin A arm and 15% in the placebo arm (P = .02) at 1 year. In an “as treated” analysis, cumulative incidence of acute GI GVHD at day +180 was 0% and 12.5% in recipients of vitamin A and placebo, respectively (P = .02), and cumulative incidence of chronic GVHD was 2.7% and 15% in recipients of vitamin A and placebo, respectively (P = .01). The only possibly attributable toxicity was asymptomatic grade 3 hyperbilirubinemia in 1 recipient of vitamin A at day +30, which self-resolved. Absolute CCR9+ CD8+ effector memory T cells, reflecting gut T-cell trafficking, were lower in the vitamin A arm at day +30 after HSCT (P = .01). Levels of serum amyloid A-1, a vitamin A transport protein with proinflammatory effects, were lower in the vitamin A arm. The vitamin A arm had lower interleukin-6 (IL-6), IL-8, and suppressor of tumorigenicity 2 levels and likely a more favorable gut microbiome and short chain fatty acids. Pre-HSCT oral vitamin A is inexpensive, has low toxicity, and reduces GVHD. This trial was registered at www.ClinicalTrials.gov as NCT03202849.


  • Open Access

    Thermoneutral Housing Enables Studies of Vertical Transmission of Obesogenic Diet-Driven Metabolic Diseases

    by Jennifer L. Wayland, Jessica R. Doll, Matthew J. Lawson, Traci E. Stankiewicz, Jarren R. Oates, Keisuke Sawada, Michelle S. M. A. Damen, Pablo C. Alarcon, David B. Haslam, Andrew T. Trout, et al.

    Vertical transmission of obesity is a critical contributor to the unabated obesity pandemic and the associated surge in metabolic diseases. Existing experimental models insufficiently recapitulate “human-like” obesity phenotypes, limiting the discovery of how severe obesity in pregnancy instructs vertical transmission of obesity. Here, via utility of thermoneutral housing and obesogenic diet feeding coupled to syngeneic mating of WT obese female and lean male mice on a C57BL/6 background, we present a tractable, more “human-like” approach to specifically investigate how maternal obesity contributes to offspring health. Using this model, we found that maternal obesity decreased neonatal survival, increased offspring adiposity, and accelerated offspring predisposition to obesity and metabolic disease. We also show that severe maternal obesity was sufficient to skew offspring microbiome and create a proinflammatory gestational environment that correlated with inflammatory changes in the offspring in utero and adulthood. Analysis of a human birth cohort study of mothers with and without obesity and their infants was consistent with mouse study findings of maternal inflammation and offspring weight gain propensity. Together, our results show that dietary induction of obesity in female mice coupled to thermoneutral housing can be used for future mechanistic interrogations of obesity and metabolic disease in pregnancy and vertical transmission of pathogenic traits.


  • Obesity in Art and Literature

    by Fiona Haslam, David Haslam

    “The truly obese had always been objects of literary and artistic satire—for grossness bespoke greed, lack of self-control and the vulgarity of temper associated with low life. But in traditional national, social and occupational stereotyping a certain stoutness was a positive property, betokening not just healthiness but the rock-solid strength of the gentleman, yeoman farmer, magistrate or citizen.” [Porter Roy, Quotation in ‘Flesh in the Age of Reason’ (London: Allen Lane Price, 2003), p.239.] Medical historians have traditionally been wary of the use of pictures as evidence of different aspects of medical practice because of the artistic license and personality cults often involved. Nevertheless, it is becoming increasingly clear that imagery is culturally determined and can be seen as part of social history. The study of obesity in art can provide useful information regarding its presence and the perceptions of how it has been viewed over several centuries. As every picture tells many stories, so every story paints many pictures. To be described as fat, corpulent, or obese is to simplify the issue; what is the narrative behind the facade? Stereotypes are built from reality and can be used to reflect social, moral, or political attitudes of the day, but to be effective, the images portrayed have to be understood by a wide audience.

  • Open Access

    MGS2AMR: a gene-centric mining of metagenomic sequencing data for pathogens and their antimicrobial resistance profile

    by Pieter-Jan Van Camp, V. B. Surya Prasath, David B. Haslam, Aleksey Porollo

    Background: Identification of pathogenic bacteria from clinical specimens and evaluating their antimicrobial resistance (AMR) are laborious tasks that involve in vitro cultivation, isolation, and susceptibility testing. Recently, a number of methods have been developed that use machine learning algorithms applied to the whole-genome sequencing data of isolates to approach this problem. However, making AMR assessments from more easily available metagenomic sequencing data remains a big challenge. Results: We present the Metagenomic Sequencing to Antimicrobial Resistance (MGS2AMR) pipeline, which detects antibiotic resistance genes (ARG) and their possible organism of origin within a sequenced metagenomics sample. This in silico method allows for the evaluation of bacterial AMR directly from clinical specimens, such as stool samples. We have developed two new algorithms to optimize and annotate the genomic assembly paths within the raw Graphical Fragment Assembly (GFA): the GFA Linear Optimal Path through seed segments (GLOPS) algorithm and the Adapted Dijkstra Algorithm for GFA (ADAG). These novel algorithms improve the sensitivity of ARG detection and aid in species annotation. Tests based on 1200 microbiome samples show a high ARG recall rate and correct assignment of the ARG origin. The MGS2AMR output can further be used in many downstream applications, such as evaluating AMR to specific antibiotics in samples from emerging intestinal infections. We demonstrate that the MGS2AMR-derived data is as informative for the entailing prediction models as the whole-genome sequencing (WGS) data. The performance of these models is on par with our previously published method (WGS2AMR), which is based on the sequencing data of bacterial isolates. Conclusions: MGS2AMR can provide researchers with valuable insights into the AMR content of microbiome environments and may potentially improve patient care by providing faster quantification of resistance against specific antibiotics, thereby reducing the use of broad-spectrum antibiotics. The presented pipeline also has potential applications in other metagenome analyses focused on the defined sets of genes.